Flag­ship takes on a pi­o­neer­ing new fund — and name — adding $285M to ad­vance its start­up mis­sion

Flag­ship has be­come one of the most promi­nent blank-slate ven­ture funds in biotech, cre­at­ing com­pa­nies from scratch in search of en­gi­neer­ing ma­jor change in the way dis­ease is treat­ed. And it will be­gin 2017 with a new fund to in­vest in the con­tin­ued growth of the com­pa­nies it sparks in­to ex­is­tence, along with a new name the Cam­bridge the MA-based group hopes will bet­ter re­flect its mis­sion.

It starts with a $285 mil­lion Spe­cial Op­por­tu­ni­ties Fund which will now op­er­ate along­side its $585 mil­lion Fund V, un­veiled 21 months ago. And the ven­ture group will be known as Flag­ship Pi­o­neer­ing as it starts its 17th year in 2017.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER